Bradykinin stimulates the ERK→Elk-1→Fos/AP-1 pathway in mesangial cells

被引:70
作者
El-Dahr, SS
Dipp, S
Baricos, WH
机构
[1] Tulane Univ, Sch Med, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA
关键词
G protein-coupled receptors; mitogen-activated protein kinase; signal transduction; cell growth;
D O I
10.1152/ajprenal.1998.275.3.F343
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Among its diverse biological actions, the vasoactive peptide bradykinin (BK) induces the transcription factor AP-1 and proliferation of mesangial cells (S. S. El-Dahr, S. Dipp, I. V. Yosipiv, and W. H. Baricos. Kidney Int. 50: 1850-1855, 1996). In the present study, we examined the role of protein tyrosine phosphorylation and the mitogen-activated protein kinases, ERK1/2, in mediating BK-induced AP-1 and DNA replication in cultured rat mesangial cells. BK (10(-9) to 10(-7) M) stimulated a rapid increase in tyrosine phosphorylation of multiple proteins with an estimated molecular mass of 120-130, 90-95, and 44-42 kDa. Immunoblots using antibodies specific for ERK or tyrosine-phosphorylated ERK revealed a shifting of p42 ERK2 to a higher molecular weight that correlated temporally with an increase in tyrosine-phosphorylated ERK2. Genistein, a specific tyrosine kinase inhibitor, prevented the phosphorylation of ERK2 by BK. In-gel kinase assays indicated that BK-induced tyrosine phosphorylation of ERK2 is accompanied by fourfold activation of its phosphotransferase activity toward the substrate PHAS-I (P < 0.05). Furthermore, BK stimulated a 2.5-fold increase (P < 0.05) in phosphorylation of Elk-1, a transcription factor required for growth factor-induced c-fos transcription. In accord with the stimulation of Elk-1 phosphorylation, BK induced c-fos gene expression and the production of Fos/AP-1 complexes. In addition, thymidine incorporation into DNA increased twofold (P < 0.05) following BK stimulation. Each of these effects was blocked by tyrosine kinase inhibition with genistein or herbimycin A. Similarly, antisense oligodeoxynucleotide targeting of ERK1/2 mRNA inhibited BK-stimulated DNA synthesis. In contrast, protein kinase C inhibition or depletion had no effect on BK-induced c-fos mRNA, AP-1-DNA binding activity, or DNA synthesis. Collectively, these data demonstrate that BK activates the ERK-->Elk-1-->AP-1 pathway and that BK mitogenic signaling is critically dependent on protein tyrosine phosphorylation.
引用
收藏
页码:F343 / F352
页数:10
相关论文
共 39 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[3]   BRADYKININ STIMULATES PRODUCTION OF INOSITOL (1,4,5) TRISPHOSPHATE IN CULTURED MESANGIAL CELLS OF THE RAT VIA A BK2-KININ RECEPTOR [J].
BASCANDS, JL ;
EMOND, C ;
PECHER, C ;
REGOLI, D ;
GIROLAMI, JP .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (04) :962-966
[4]   EVIDENCE FOR EXISTENCE OF 2 DISTINCT BRADYKININ RECEPTORS ON RAT MESANGIAL CELLS [J].
BASCANDS, JL ;
PECHER, C ;
ROUAUD, S ;
EMOND, C ;
TACK, JL ;
BASTIE, MJ ;
BURCH, R ;
REGOLI, D ;
GIROLAMI, JP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (03) :F548-F556
[5]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[6]   Multiple intracellular MAP kinase signaling cascades [J].
Bokemeyer, D ;
Sorokin, A ;
Dunn, MJ .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1187-1198
[7]   INVOLVEMENT OF PROTEIN-KINASE-C AND CA2+ IN ANGIOTENSIN-II-INDUCED MITOGENESIS OF CARDIAC FIBROBLASTS [J].
BOOZ, GW ;
DOSTAL, DE ;
SINGER, HA ;
BAKER, KM .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1994, 267 (05) :C1308-C1318
[8]  
Breyer JA, 1995, J AM SOC NEPHROL, V6, P1523
[9]   EFFECTS OF CONVERTING-ENZYME INHIBITORS ON ANGIOTENSIN AND BRADYKININ PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1994, 23 (04) :439-449
[10]   Bombesin and neuromedin B stimulate the activation of p42(mapk) and p74(raf-1) via a protein kinase C-independent pathway in Rat-1 cells [J].
Charlesworth, A ;
Rozengurt, E .
ONCOGENE, 1997, 14 (19) :2323-2329